Compare Cineverse Corp. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 2.32%
- The company has been able to generate a Return on Equity (avg) of 2.32% signifying low profitability per unit of shareholders funds
2
With a fall in Net Sales of -28.61%, the company declared Very Negative results in Jun 25
3
Risky - Market Cap of less than 100 cr
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.8%
0%
-47.8%
6 Months
-48.09%
0%
-48.09%
1 Year
120.93%
0%
120.93%
2 Years
-52.97%
0%
-52.97%
3 Years
-85.55%
0%
-85.55%
4 Years
-93.95%
0%
-93.95%
5 Years
-95.94%
0%
-95.94%
Cineverse Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.69%
EBIT Growth (5y)
29.56%
EBIT to Interest (avg)
-1.71
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
1.47
Tax Ratio
2.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.64%
ROCE (avg)
7.56%
ROE (avg)
2.32%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.58
EV to EBIT
7.93
EV to EBITDA
5.21
EV to Capital Employed
1.61
EV to Sales
0.79
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
20.30%
ROE (Latest)
10.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (5.14%)
Foreign Institutions
Held by 12 Foreign Institutions (0.61%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
12.40
11.10
11.71%
Operating Profit (PBDIT) excl Other Income
-4.30
-2.60
-65.38%
Interest
0.10
0.00
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-5.50
-3.50
-57.14%
Operating Profit Margin (Excl OI)
-437.80%
-328.70%
-10.91%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 11.71% vs -28.85% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -57.14% vs -488.89% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
78.20
49.10
59.27%
Operating Profit (PBDIT) excl Other Income
11.80
3.40
247.06%
Interest
4.40
1.10
300.00%
Exceptional Items
0.10
-19.70
100.51%
Consolidate Net Profit
3.80
-21.30
117.84%
Operating Profit Margin (Excl OI)
102.50%
-6.90%
10.94%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 59.27% vs -27.79% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 117.84% vs -119.59% in Mar 2024
About Cineverse Corp. 
Cineverse Corp.
Media & Entertainment
Cinedigm Corp. is a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, and home and mobile entertainment platforms. The Company also provides digital cinema assets servicing on over 12,000 domestic and foreign movie screens. It operates through four segments: first digital cinema deployment (Phase I Deployment), the second digital cinema deployment (Phase II Deployment), digital cinema services and media content and entertainment group. It collaborates with producers, brands and other content owners to market, source, curate and distribute content to targeted audiences. It distributes content through existing and emerging digital home entertainment platforms and packaged distribution of DVD and Blu-ray discs to wholesalers and retailers and mortar storefronts. It also operates a branded and curated over-the-top entertainment channels.
Company Coordinates 
Company Details
237 WEST 35TH STREET, SUITE 605 , NEW YORK NY : 10001
Registrar Details






